TITLE

EURAND IN-LICENSES NOVEL ANALGESICS

PUB. DATE
March 2006
SOURCE
Worldwide Biotech;Mar2006, Vol. 18 Issue 3, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that specialty pharmaceutical company Eurand has signed research agreements with two Universities in Italy to evaluate a class of analgesic compounds. Expectation on the class of analgesic compounds; Terms of the agreement; Comments from company CEO Gearoid Faherty on the research agreement.
ACCESSION #
20451869

 

Related Articles

  • FDA APPROVALS IN AUGUST.  // BioWorld Insight;9/14/2009, Vol. 17 Issue 37, p7 

    The article presents the pharmaceutical companies in the U.S. with their medicines and indications which received the approval from the Food and Drug Administration (FDA) in August 2009 which include Kowa Pharmaceuticals America Inc., Eurand NV, Janssen Pharmaceutica NV and King Pharmaceuticals Inc.

  • Legal Pains from Super Painkiller.  // Perspective (08889732);May2004, Vol. 19 Issue 5, p5 

    Reports that the federal appeals court has upheld the dismissal of a lawsuit brought by the University of Rochester (UR), New York. Effort of the school to stop a major pharmaceutical company from using a UR patent to make the painkiller drug Celebrex; Claims of the UR; Injunction to halt...

  • Eurand completes EU registration procedure for paracetamol ODT tablets.  // PharmaWatch: CNS;Sep2009, Vol. 8 Issue 9, p21 

    The article reports that Eurand NV completed the registration of 250 and 500 milligrams (mg) paracetamol orodispersible tablets (ODT) in European Union (EU) countries. It notes that paracetamol is a widely utilized analgesic and paracetamol ODT is for treating mild-to moderate pain. It states...

  • The Synergy between Contract Manufacturing and Pharmaceutical Research and Development. Fites, A.L.; Gooding, D.L.; Hardwick, L.M.; Kruszynski, M.; Massey, E.H.; Oslos, E.; Saffell-Clemmer, W.; Vaughn, D.A.; Akers, M.J. // Pharmaceutical Technology;Aug2003 Supplement, Vol. 27 Issue 8, p68 

    Focuses on the synergy between contract manufacturing and pharmaceutical research and development (PRD). Definition of PRD; Projects that may be calculated in a PRD laboratory; Other contributions made by PRD staff.

  • Drug Delivery Industry Profile: Europe.  // Drug Delivery Industry Profile: Europe;Oct2006, p1 

    Presents a profile of the Drug Delivery industry in Europe. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • Drug Delivery in Italy.  // Drug Delivery Industry Profile: Italy;November 2004, p1 

    Presents a profile of the Drug Delivery industry in Italy. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • WEEK IN REVIEW.  // BioWorld Insight;9/7/2009, Vol. 17 Issue 36, p6 

    The article offers news related to biotechnology financings and deals in the U.S. It relates that Eurand NV has obtained approval of its Zenpep (pancrelipase) delayed-release capsules from the Food and Drug Administration (FDA). It mentions that Algeta ASA has received an 800 million dollars...

  • Taste-masked pseudoephedrine.  // Drug Topics;2/19/96, Vol. 140 Issue 4, p8 

    Focuses on Eurand's development of a taste-masked pseudoephedrine using technology called Microcaps.

  • ZENPEP 5000.  // Monthly Prescribing Reference;Feb2010, Vol. 26 Issue 2, pA17 

    The article evaluates the Zenpep 5000 medicine for the treatment of pancreatic insufficiency from Eurand NV.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics